After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Editas Medicine Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Editas Medicine Inc is $194.26M. A total of 2.2 million shares were traded on the day, compared to an average of 2.20M shares.
In the most recent transaction, Burkly Linda sold 713 shares of EDIT for 2.15 per share on Dec 03 ’25. After the transaction, the EVP, CHIEF SCIENTIFIC OFFICER now owns 68,777 company shares. In a previous transaction on Dec 03 ’25, O’Neill Gilmore Neil sold 5,603 shares at 2.15 per share. EDIT shares that CEO owns now total 269,087.
Among the insiders who sold shares, Parison Amy disposed of 461 shares on Dec 03 ’25 at a per-share price of $2.15. This resulted in the SVP, Chief Financial Officer holding 15,908 shares of EDIT after the transaction. In another insider transaction, O’Neill Gilmore Neil bought 7,000 shares at $2.50 per share on Dec 03 ’25.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, EDIT has a high of $4.54 and a low of $0.91.
As of this writing, EDIT has an earnings estimate of -$0.21 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of $0.08 per share and a lower estimate of -$0.34. The company reported an EPS of -$0.55 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. EDIT’s latest balance sheet shows that the firm has $499.85M in Cash & Short Term Investments as of fiscal 2021. There were $26.38M in debt and $46.88M in liabilities at the time. Its Book Value Per Share was $0.14, while its Total Shareholder’s Equity was $553.64M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EDIT is Buy with a score of 3.65.
